Goldman Sachs Group »

Acelyrin shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.3M 1.1M 7.46
2023-09-30 $18M 1.8M 10.17
2023-06-30 $6.5M 310k 20.90

More positions owned by Goldman Sachs Group

Spdr S&p 500 Etf Tr CMN (SPY)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Ishares Tr CMN (IWM)
Amazon CMN (AMZN)
Nvidia Corporation CMN (NVDA)
Invesco Qqq Tr CMN (QQQ)
Ishares Tr CMN (IVV)
Tesla CMN (TSLA)
Alphabet CMN (GOOGL)
Meta Platforms CMN (META)
Vanguard Index Fds CMN (VOO)
Visa CMN (V)
Ishares Tr CMN (HYG)
Ishares Tr CMN (EFA)

View all positions for Goldman Sachs Group

Top funds holding Acelyrin

Citadel Advisors
Vanguard Group
Opaleye Management
OrbiMed Advisors
venBio Partners
Jpmorgan Chase & Co
Artal Group
Samsara BioCapital
Ikarian Capital
Blue Owl Capital Holdings
Henderson Group
Decheng Capital
Logos Global Management
Kynam Capital Management
Goldman Sachs Group

View all funds holding Acelyrin